Regional Access to Acute Ischemic Stroke Intervention
Author(s) -
Richard J. Riopelle,
David Howse,
C. F. Bolton,
Steve Elson,
Dianne Groll,
D. Holtom,
Donald Brunet,
Alan C. Jackson,
Michel Melanson,
Donald F. Weaver
Publication year - 2001
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.32.3.652
Subject(s) - medicine , stroke (engine) , referral , psychological intervention , emergency medicine , thrombolysis , tissue plasminogen activator , emergency medical services , acute stroke , population , medical emergency , acute care , health care , myocardial infarction , family medicine , nursing , mechanical engineering , environmental health , engineering , economics , economic growth
Benefit-risk ratios from recombinant tissue plasminogen activator (rtPA) therapy for acute ischemic stroke demonstrate lack of efficacy if intravenous administration is commenced beyond 3 hours of symptom onset. We undertook to enhance therapeutic effectiveness by ensuring equitable access to rtPA for patients affected by acute ischemic stroke within a 20 000 km(2) population referral base served by a tertiary facility.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom